|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Marble | CAS 1317-65-3 | ||
| CaCO3 | RTECS EV9580000 | ||
|
Synonyms & Trade Names Calcium carbonate, Natural calcium carbonate [Note: Marble is a metamorphic form of calcium carbonate.] |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 10 mg/m3 (total) TWA 5 mg/m3 (resp) | ||
| OSHA PEL: TWA 15 mg/m3 (total) TWA 5 mg/m3 (resp) | |||
| IDLH N.D. | Conversion | ||
|
Physical Description Odorless, white powder. |
|||
|
MW: 100.1 |
BP: Decomposes |
MLT: 1517-2442°F (Decomposes) |
Sol: 0.001% |
|
VP: 0 mmHg (approx) |
IP: NA |
|
Sp.Gr: 2.7-2.9 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Solid | |||
|
Incompatibilities & Reactivities Fluorine, magnesium, acids, alum, ammonium salts |
|||
|
Measurement Methods NIOSH 0500, 0600 |
|
Personal Protection & Sanitation Skin: No recommendation Eyes: No recommendation Wash skin: No recommendation Remove: No recommendation Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Fresh air |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, skin and/or eye contact | |
| Symptoms Irritation eyes, skin, mucous membrane, upper respiratory system; cough, sneezing, rhinorrhea (discharge of thin mucus); lacrimation (discharge of tears) | |
|
Target Organs
Eyes, skin, respiratory system |
|
| See also: INTRODUCTION |